Peony Exploratory Analyses of Biomarker Changes - from baseline to surgical samples in HER2+ Breast Cancer patients
| Title | Peony Exploratory Analyses of Biomarker Changes - from baseline to surgical samples in HER2+ Breast Cancer patients |
|---|---|
| Description | One study evaluated patients with early-stage or locally advanced HER2-positive breast cancer who received pertuzumab plus docetaxel, trastuzumab (neoadjuvant therapy) before surgery, and pertuzumab plus trastuzumab after postoperative chemotherapy. The data of the randomized, multi-center, double-blind, placebo-controlled phase III study of zizumab (adjuvant therapy) were released at the conference, including HER2 FISH, HER2/3 mRNA and PIK3CA report data, and did not involve sequencing. |
| Organism | Homo sapiens |
| Data Type | Genetic Biomarkers |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA025141 |
| Release Date | 2024-04-11 |
| Submitter | Lanyun Xiang (lanyun.xiang@tigermedgrp.com) |
| Organization | Hangzhong Tigermed Consulting Co., Ltd. |
| Submission Date | 2024-04-10 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX006201-01 | HER2 FISH, HER2/3 mRNA and PIK3CA report data | 261 | Genetic Biomarkers | 435.0 KB | xlsx | 0 | Unavailable |